TY  - GEN
AU  - Betancor, Gilberto
AU  - Garriga, Cesar
AU  - Puertas, Maria C
AU  - Nevot, María
AU  - Anta, Lourdes
AU  - Blanco, José L
AU  - Pérez-Elías, María-Jesús
AU  - de Mendoza, Carmen
AU  - Martínez, Miguel A
AU  - Martinez-Picado, Javier
AU  - Menéndez-Arias, Luis
AU  - Resistance Platform of the Spanish AIDS Research Network (ResRIS)
AU  - Perez-Olmeda, Mayte
AU  - Alcamí, José
PY  - 2012
DO  - 10.1186/1742-4690-9-68
SN  - 1742-4690
UR  - http://hdl.handle.net/20.500.12105/7171
AB  - BACKGROUND: Thymidine analogue resistance mutations (TAMs) selected under treatment with nucleoside analogues generate two distinct genotypic profiles in the HIV-1 reverse transcriptase (RT): (i) TAM1: M41L, L210W and T215Y, and (ii) TAM2: D67N, K70R...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Adenine
KW  - Anti-HIV Agents
KW  - Deoxycytidine
KW  - Emtricitabine
KW  - HIV Infections
KW  - HIV Reverse Transcriptase
KW  - HIV-1
KW  - Humans
KW  - Molecular Sequence Data
KW  - Organophosphonates
KW  - Selection, Genetic
KW  - Sequence Analysis, DNA
KW  - Tenofovir
KW  - Treatment Failure
KW  - Drug Resistance, Viral
KW  - Mutation, Missense
TI  - Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
TY  - research article
ER  -